Floatz logo

Paricalcitol

Proteinuria

Federico II UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Proteinuria cohort.

Asset / SponsorPhaseRating
VALSARTAN
Columbia University
Phase 4BB
Semaglutide
University Medical Center Groningen
Phase 3BB
Aliskiren
Columbia University
Phase 4CCC
Huaier Granule
Fudan University
Phase 2CCC
Losartan
University of Alabama at Birmingham
Phase 2CCC
Empagliflozin
University of Illinois at Chicago
Phase 2CCC
Enalapril
University of Alabama at Birmingham
D

Same molecule, other indications

Paricalcitol is also rated in:

pancreatic adenocarcinomaDormant
B
Indicative ·
62 / 100
View asset →
malignant pancreatic neoplasmDormant
B
Indicative ·
60 / 100
View asset →
pancreatic neoplasmDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →